Eli Lilly ties up with MSN Labs, Torrent Pharma for sale of Covid-19 drug Baricitnib in India

Eli Lilly ties up with MSN Labs, Torrent Pharma for sale of Covid-19 drug Baricitnib in India
Baricitinib has received 'restricted emergency use approval' from the health ministry's central drugs standard control organisation for use in combination with Remdesivir for treatment of suspected or confirmed COVID-19 patients
BusinessToday.In | May 13, 2021 | Updated 12:33 IST
Lilly is engaged in active dialogue with regulatory authorities and government to donate anti-COVID-19 treatments
Eli Lilly has signed additional voluntary licences with MSN Labs and Torrent Pharma for manufacturing and sale of Covid-19 drug Baricitnib in India. The pacts with these two companies have been signed after US-based Lilly entered into an agreement with five homegrown pharma companies.

Related Keywords

India ,Eli Lilly ,Cipla ,Torrent Pharma ,Sun Pharmaceutical ,Direct Relief ,Eli Lilly Ties Up With Msn Labs ,Covid 19 Drug Baricitnib ,Dr Reddys To Make Baricitinib ,Dr Reddys Get Baricitinib Licence ,Baricitinib Manufacturing In India ,Cipla Ties Up With Eli Lilly ,Covid 19 Treatment In India ,Baricitinib For Covid 19 , ,இந்தியா ,எலி லில்லி ,சிப்லா ,நீரோடை பார்மா ,சூரியன் மருந்து ,நேரடி துயர் நீக்கம் ,